MORRAB SURGERY
2 MORRAB ROAD, PENZANCE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 15 | 80.0% | |
| HF 4 | 2011 | 16 | 19 | 84.2% | |
| HF 4 | 2012 | 19 | 22 | 86.4% | |
| HF 4 | 2013 | 21 | 24 | 87.5% | |
| HF004 | 2014 | 20 | 20 | 100.0% | |
| HF004 | 2015 | 19 | 19 | 100.0% | |
| HF004 | 2016 | 19 | 19 | 100.0% | |
| HF004 | 2017 | 16 | 17 | 94.1% | |
| HF004 | 2018 | 34 | 35 | 97.1% | |
| HF004 | 2020 | 30 | 34 | 88.2% | |
| HF006 | 2021 | 45 | 52 | 86.5% | |
| HF006 | 2022 | 46 | 50 | 92.0% | |
| HF006 | 2023 | 62 | 64 | 96.9% |
